A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: MKC-1
Sponsor: CASI Pharmaceuticals, Inc.